NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.
Schotten C, Bechmann LP, Manka P, Theysohn J, Dechêne A, El Fouly A, Barbato F, Neumann U, Radünz S, Sydor S, Heider D, Venerito M, Canbay A, Gerken G, Herrmann K, Wedemeyer H, Best J.
Schotten C, et al.
Liver Cancer. 2019 Nov;8(6):491-504. doi: 10.1159/000501484. Epub 2019 Jul 29.
Liver Cancer. 2019.
PMID: 31799206
Free PMC article.